- Home
- LILA vs QDEL Comparison
LILA vs QDEL Comparison
Compare LILA & QDEL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | LILA | QDEL |
|---|---|---|
| Founded | 2017 | 1979 |
| Country | Bermuda | United States |
| Employees | 10000 | N/A |
| Industry | Cable & Other Pay Television Services | Medical Specialities |
| Sector | Telecommunications | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.5B | 1.6B |
| IPO Year | N/A | 2022 |
Fundamental Metrics
Financial Performance| Metric | LILA | QDEL |
|---|---|---|
| Price | $7.82 | $15.30 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 1 | 4 |
| Target Price | $13.00 | ★ $32.75 |
| AVG Volume (30 Days) | 296.7K | ★ 1.2M |
| Earning Date | 05-06-2026 | 05-06-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 45.35 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $2,730,200,000.00 |
| Revenue This Year | N/A | $3.51 |
| Revenue Next Year | $7.46 | $3.86 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $4.25 | $16.16 |
| 52 Week High | $9.04 | $37.24 |
Technical Indicators
Market Signals| Indicator | LILA | QDEL |
|---|---|---|
| Relative Strength Index (RSI) | 50.44 | 25.49 |
| Support Level | $7.37 | N/A |
| Resistance Level | $8.19 | $30.65 |
| Average True Range (ATR) | 0.26 | 1.14 |
| MACD | 0.00 | -0.18 |
| Stochastic Oscillator | 62.07 | 2.32 |
Price Performance
Historical ComparisonAbout LILA Liberty Latin America Ltd.
Liberty Latin America Ltd is a telecommunications company. It is a provider of video, broadband internet, fixed-line telephony, and mobile services to residential and business customers. The company's reportable segments include C&W Caribbean, Liberty Networks, C&W Panama, VTR, Liberty Puerto Rico and Liberty Costa Rica. The company generates the majority of its revenue from C&W Caribbean, and Liberty Puerto Rico segments.
About QDEL QuidelOrtho Corporation
QuidelOrtho Corp is engaged in the development, manufacturing, and marketing of rapid diagnostic testing solutions. The company is engaged in immunoassay and molecular testing, clinical chemistry, and transfusion medicine, which helps clinicians and patients to make decisions across the globe. Geographically, the company has its presence in North America, EMEA, China, and Other countries. It generates the majority of its revenue from North America.